Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratinocytes | 4 | 2021 | 791 | 1.750 |
Why?
|
| Burns | 3 | 2021 | 1882 | 0.750 |
Why?
|
| Skin, Artificial | 1 | 2019 | 89 | 0.650 |
Why?
|
| Antioxidants | 2 | 2024 | 1668 | 0.600 |
Why?
|
| Tissue Engineering | 3 | 2021 | 1868 | 0.530 |
Why?
|
| Dermatitis, Perioral | 1 | 2014 | 1 | 0.480 |
Why?
|
| Cheilitis | 1 | 2014 | 7 | 0.480 |
Why?
|
| Blister | 1 | 2014 | 86 | 0.460 |
Why?
|
| Erythema | 1 | 2014 | 262 | 0.420 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.380 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2014 | 283 | 0.380 |
Why?
|
| Urology | 1 | 2014 | 400 | 0.330 |
Why?
|
| Fibroblasts | 1 | 2019 | 4141 | 0.330 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3801 | 0.290 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2141 | 0.260 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10448 | 0.240 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 11461 | 0.220 |
Why?
|
| Volatile Organic Compounds | 1 | 2023 | 86 | 0.210 |
Why?
|
| Neurofilament Proteins | 1 | 2024 | 336 | 0.200 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2023 | 127 | 0.190 |
Why?
|
| Iran | 1 | 2024 | 737 | 0.190 |
Why?
|
| Nutritive Value | 1 | 2024 | 350 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18965 | 0.180 |
Why?
|
| Rejuvenation | 1 | 2021 | 107 | 0.170 |
Why?
|
| Gastritis, Atrophic | 1 | 2019 | 31 | 0.170 |
Why?
|
| Alopecia | 1 | 2023 | 412 | 0.160 |
Why?
|
| Caffeine | 1 | 2023 | 700 | 0.160 |
Why?
|
| Risk Reduction Behavior | 1 | 2024 | 1112 | 0.150 |
Why?
|
| Enzyme Activators | 1 | 2017 | 57 | 0.150 |
Why?
|
| Gastric Mucosa | 1 | 2019 | 604 | 0.130 |
Why?
|
| Verapamil | 1 | 2016 | 242 | 0.130 |
Why?
|
| Adult Stem Cells | 1 | 2017 | 221 | 0.130 |
Why?
|
| Persia | 1 | 2014 | 7 | 0.120 |
Why?
|
| Telomere | 1 | 2021 | 943 | 0.120 |
Why?
|
| History, Medieval | 1 | 2014 | 62 | 0.120 |
Why?
|
| Lethargy | 1 | 2014 | 43 | 0.120 |
Why?
|
| Skin Transplantation | 1 | 2019 | 1083 | 0.120 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 598 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2019 | 933 | 0.110 |
Why?
|
| Acid-Base Equilibrium | 1 | 2014 | 181 | 0.110 |
Why?
|
| Lipid Peroxidation | 1 | 2014 | 271 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 2016 | 694 | 0.110 |
Why?
|
| Consanguinity | 1 | 2014 | 456 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2024 | 3728 | 0.100 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 524 | 0.090 |
Why?
|
| Aging | 2 | 2021 | 8711 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2023 | 2877 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 1459 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 1600 | 0.080 |
Why?
|
| Regeneration | 1 | 2017 | 1512 | 0.080 |
Why?
|
| Administration, Topical | 2 | 2023 | 704 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2014 | 1152 | 0.080 |
Why?
|
| Humans | 15 | 2024 | 761572 | 0.080 |
Why?
|
| Skin | 1 | 2021 | 4484 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2024 | 22176 | 0.070 |
Why?
|
| Wound Healing | 1 | 2016 | 2805 | 0.060 |
Why?
|
| Neoplasms | 1 | 2014 | 22173 | 0.060 |
Why?
|
| Depression | 1 | 2024 | 8124 | 0.060 |
Why?
|
| Minoxidil | 1 | 2023 | 34 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 2491 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2024 | 23996 | 0.050 |
Why?
|
| Mitochondria | 1 | 2014 | 3624 | 0.050 |
Why?
|
| Metaplasia | 1 | 2019 | 322 | 0.040 |
Why?
|
| Morbidity | 1 | 2023 | 1750 | 0.040 |
Why?
|
| Risk Factors | 1 | 2024 | 74213 | 0.040 |
Why?
|
| Male | 5 | 2024 | 360842 | 0.030 |
Why?
|
| Therapeutics | 1 | 2016 | 113 | 0.030 |
Why?
|
| ROC Curve | 1 | 2023 | 3579 | 0.030 |
Why?
|
| Gels | 1 | 2016 | 420 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 220920 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 169310 | 0.030 |
Why?
|
| Photography | 1 | 2016 | 532 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 221203 | 0.030 |
Why?
|
| Female | 3 | 2024 | 392686 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2016 | 1045 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 1848 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 36192 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2395 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 42230 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1626 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 14666 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 4853 | 0.020 |
Why?
|
| Animals | 2 | 2016 | 168467 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2019 | 5079 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8656 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8633 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11076 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29629 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13510 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 21355 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 23741 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 20571 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18253 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 64684 | 0.010 |
Why?
|
| Young Adult | 1 | 2023 | 59255 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39107 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 80646 | 0.010 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_